The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCAR-T 2019 | Day 1 round up: CAR-T toxicity
From the 1st International Workshop on CAR-T (iwCAR-T), held in Miami, FL, John Gribben, MD, DSc, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, Noelle Frey, MD, University of Pennsylvania, Philadelphia, PA, and David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discuss the current updates in CAR-T toxicity. The speakers share their thoughts on managing CAR T-cell therapy-related toxicity and discuss the consensus grading scale for CRS and neurotoxicity.
